China represents a strategic priority market for many companies and investors in today’s evolving life sciences industry. Featuring the unique insights of our full-service legal team in China, this site contains valuable resources to assist clients in navigating the legal complexities of market conditions and industry trends within the region. Learn more.
The Centers for Medicare & Medicaid Services issued a proposed rule that, if finalized, would modify significantly the current Medicaid Drug Rebate Program regulations. The proposed rule puts forth new regulatory policies, as well as provides clarification with regard to ...
Law360 has named four Ropes & Gray attorneys to its 2020 “Rising Stars” list. Blockchain and emerging technologies attorney Marta Belcher (Silicon Valley) was recognized as a Fintech Rising Star; corporate partner Zachary Blume (Boston) was recognized ...
FDA regulatory partner and practice chair Greg Levine (Washington, D.C.) presented at the Food and Drug Law Institute’s webinar on April 14 titled “FDA’s Recent COVID-19 Guidances Facilitating Expanded Access to Certain Medical ...
